Tata India Pharma & Healthcare Fund-Direct(IDCW)RI
Tata India Pharma & Healthcare Fund-Direct(IDCW)RI Overview
Holdings Distribution
Top Holdings
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Direct(IDCW)RI | 5.31% | 25.29% | 14.89% |
| Canara Robeco Banking and Financial Services Fund - Reg (G) | N/A | N/A | N/A |
| The Wealth Company Small Cap Fund - Direct (IDCW) | N/A | N/A | N/A |
| The Wealth Company Small Cap Fund - Regular (G) | N/A | N/A | N/A |
| Abakkus Small Cap Fund - Direct (G) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Reg (IDCW) | N/A | N/A | N/A |
Scheme Information
Tata India Pharma & Healthcare Fund-Direct(IDCW)RI was launched on 04/12/2015. The fund manages ₹1,325 Cr in assets. Its current expense ratio is 0.83%.
Fund Manager: Rajat Srivastava
Returns Calculator
Calculate your investment growth with SIP or Lumpsum.
FAQs on Tata India Pharma & Healthcare Fund-Direct(IDCW)RI
The current expense ratio of Tata India Pharma & Healthcare Fund-Direct(IDCW)RI is 0.83%.
The AUM of Tata India Pharma & Healthcare Fund-Direct(IDCW)RI is ₹1,325 crore.
Log in to your investment platform, select the fund, enter units or amount, and confirm the redemption request.
Yes, Tata India Pharma & Healthcare Fund-Direct(IDCW)RI allows both SIP and lump sum investments.
The latest NAV is ₹36.08.
Minimum SIP starts from ₹100.
Redemption can be done via AMC website or your investment platform.
